Harbor Investment Advisory’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
Other funds holding BIIB
AIM
Harbor Investment Advisory's BIIB Position: Q2 2026 in Review
Harbor Investment Advisory held its Biogen (BIIB) position steady in Q2 2026 at 18 shares worth $3.89K. The position accounts for ﹤0.01% of the portfolio, ranked #1155.
Harbor Investment Advisory first reported a position in BIIB in Q4 2019 and has held it in 27 quarters since. The position peaked at $538K in Q1 2020. 569 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.
- Harbor Investment Advisory held 18 shares of Biogen worth $3.89K as of Q2 2026.
- Harbor Investment Advisory left its Biogen share count unchanged in Q2 2026.
- Biogen made up ﹤0.01% of Harbor Investment Advisory's portfolio in Q2 2026, its #1155 holding.
- Harbor Investment Advisory first reported a position in Biogen in Q4 2019 and has held it in 27 quarters since.
- Harbor Investment Advisory's Biogen position peaked at $538K in Q1 2020.
- 569 funds tracked by Wall St. Rank held Biogen as of Q2 2026.
Based on Harbor Investment Advisory's 13F filing for Q2 2026, filed 7 Jul 2026.